Day One was one of three parties interested in Mersana; Bihua Chen and Cormorant’s third SPAC

Plus, news about Bicara Therapeutics, Boehringer Ingelheim, Gubra, AbbVie, OSE Immunotherapeutics, Encoded Therapeutics, UCB and Immix Biopharma: 🤝 Two other companies were interested in Mersana: Day One wasn’t the only company to submit offers ...